Shimla Online

Cataplexy Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies – Axome Therapeutics, Suven Therapeutics , Takeda , Avel Therapeutics

 Breaking News
  • No posts were found

Cataplexy Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies – Axome Therapeutics, Suven Therapeutics , Takeda , Avel Therapeutics

April 06
17:04 2023
Cataplexy Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Axome Therapeutics, Suven Therapeutics , Takeda , Avel Therapeutics
DelveInsight Business Research LLP
DelveInsight’s “Cataplexy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cataplexy, historical and forecasted epidemiology as well as the Cataplexy market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Cataplexy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cataplexy, historical and forecasted epidemiology as well as the Cataplexy market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

 Cataplexy Overview

Cataplexy is a sudden and transient episode of muscle weakness accompanied by full conscious awareness, typically triggered by emotions such as laughing, crying, or terror.[1] Cataplexy affects approximately 70% of people who have narcolepsy, and is caused by the autoimmune destruction of hypothalamic neurons that produce the neuropeptide hypocretin (also called orexin), which regulates arousal and has a role in the stabilization of the transition between wake and sleep states.] Cataplexy without narcolepsy is rare and the cause is unknown.

The term cataplexy originates from the Greek κατά (kata, meaning “down”), and πλῆξις (plēxis, meaning “strike”), and it was first used around 1880 in German physiology literature to describe the phenomenon of tonic immobility also known as “playing possum” (in reference to the opossum’s behavior of feigning death when threatened). In the same year, the French neuropsychiatrist Jean-Baptiste Gélineau coined the term ‘narcolepsy’ and published some clinical reports that contain details about two patients who have similar conditions as the narcoleptic cases nowadays. Nevertheless, the onset reported by him was in adulthood as compared to the nowadays cases reported in childhood and adolescence. Even if he preferred the term ‘astasia’ instead of ‘cataplexy’ the case described by him remained iconic for the full narcoleptic syndrome

 

 The Report Covers the Cataplexy Epidemiology Segmented by –

  • Cataplexy prevalent cases 

  • Cataplexy incident cases 

  • Cataplexy diagnosed cases 

  • Cataplexy treatment cases 

Cataplexy Market Outlook 

The Cataplexy market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Cataplexy market trends by analyzing the impact of current Cataplexy therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Cataplexy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Cataplexy market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Cataplexy market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Cataplexy Market include:

  • Axome Therapeutics 

  • Suven Therapeutics 

  • Takeda 

  • Avel Therapeutics 

And many others 

Cataplexy Therapies Covered in the Report:

  • SUVN-G3031

  • AXS-12 (reboxetine)

  • FT218

  • TAK-861

And many others 

Table of Contents

  1. Key Insights 

  2. Report Introduction 

  3. Executive Summary of Cataplexy  Market 

  4. Cataplexy Background and Overview

  5. Cataplexy Epidemiology and patient population

  6. Cataplexy Market Emerging Therapies

  7. Cataplexy Market Cancer Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Appendix

  10. Market Report Methodology

  11. DelveInsight Capabilities

  12. Disclaimer

  13. About DelveInsight

Learn more about detailed report offerings @ Cataplexy  Market Outlook

Trending Reports by DelveInsight

  • Adalimumab Biosimilar Market

  • Arbovirus Infection Market

  • Artificial Pancreas Device System Market

  • Dental Equipment Market

  • Gluten Sensitivity Market

  • Hypothyroidism Market

  • Inflammatory Bowel Disease Market

  • Mayus Kinase Jak Inhibitors Market

  • Mild Dry Eye Market

  • Mucopolysaccharidosis Market

  • Oncolytic Virus Cancer Therapy Market

  • Pyoderma Gangrenosum Market

  • Transdermal Drug Delivery Devices Market

  • Intrathecal Pumps Market

  • Hedgehog Pathway Inhibitors Market

  • Yellow Fever Market

  • Laryngeal Cancer Market

  • Female Infertility Market

  • Gender Dysphoria Market

  • Cataplexy  Market

  • Spain Healthcare Outlook Market

  • Malignant Fibrous Histiocytoma Market

Related Reports

Cataplexy Pipeline Insight

DelveInsight’s, “Cataplexy – Pipeline Insights, 2023,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Cataplexy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Related Articles